Bleeding incidence rates during anticoagulant therapy
| . | No. of patients . | Bleeds per 100 patient-years (95% CI) . |
|---|---|---|
| Major bleeding, mo | ||
| 0-3 | 981 | 21.4 (16.1-28.4) |
| 0-1 | 981 | 44.9 (32.2-62.5) |
| 1-3 | 910 | 8.9 (5.2-15.3) |
| 3-36 | 827 | 5.4 (4.1-7.1) |
| 3-12 | 827 | 7.5 (5.3-10.6) |
| 12-36 | 418 | 3.7 (2.4-5.8) |
| Clinically relevant nonmajor bleeding, mo | ||
| 0-3 | 981 | 22.3 (16.9-29.4) |
| 0-1 | 981 | 33.2 (22.6-48.7) |
| 1-3 | 913 | 16.5 (11.0-24.5) |
| 3-36 | 823 | 11.0 (9.0-13.5) |
| 3-12 | 823 | 14.8 (11.5-19.0) |
| 12-36 | 385 | 7.8 (5.6-10.8) |
| . | No. of patients . | Bleeds per 100 patient-years (95% CI) . |
|---|---|---|
| Major bleeding, mo | ||
| 0-3 | 981 | 21.4 (16.1-28.4) |
| 0-1 | 981 | 44.9 (32.2-62.5) |
| 1-3 | 910 | 8.9 (5.2-15.3) |
| 3-36 | 827 | 5.4 (4.1-7.1) |
| 3-12 | 827 | 7.5 (5.3-10.6) |
| 12-36 | 418 | 3.7 (2.4-5.8) |
| Clinically relevant nonmajor bleeding, mo | ||
| 0-3 | 981 | 22.3 (16.9-29.4) |
| 0-1 | 981 | 33.2 (22.6-48.7) |
| 1-3 | 913 | 16.5 (11.0-24.5) |
| 3-36 | 823 | 11.0 (9.0-13.5) |
| 3-12 | 823 | 14.8 (11.5-19.0) |
| 12-36 | 385 | 7.8 (5.6-10.8) |